ARS Pharmaceuticals (SPRY) has issued an announcement.
ARS Pharmaceuticals, Inc. has refreshed its corporate presentation, which can now be accessed on its website. This latest update, designed to inform investors and analysts, features in a recent report but is not intended for official filing purposes under securities laws. Interested parties are encouraged to review the new presentation to stay current with the company’s developments.
See more insights into SPRY stock on TipRanks’ Stock Analysis page.
